Cargando…
Immunoglobulin, glucocorticoid, or combined therapy for multisystem inflammatory syndrome in children
Autores principales: | Chew, Christine, Ramanan, Athimalaipet V |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Elsevier Ltd.
2023
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9928483/ https://www.ncbi.nlm.nih.gov/pubmed/36817950 http://dx.doi.org/10.1016/S2665-9913(23)00035-8 |
Ejemplares similares
-
Steroids or intravenous immunoglobulin as first line in MIS-C in LMICs
por: Crosby, Laura, et al.
Publicado: (2021) -
Anakinra in Refractory Multisystem Inflammatory Syndrome in Children (MIS-C)
por: Bhat, Chandrika S., et al.
Publicado: (2021) -
Immunoglobulin, glucocorticoid, or combination therapy for multisystem inflammatory syndrome in children: a propensity-weighted cohort study
por: Channon-Wells, Samuel, et al.
Publicado: (2023) -
Understanding SARS-CoV-2-related multisystem inflammatory syndrome in children
por: Rowley, Anne H.
Publicado: (2020) -
Multisystemic Inflammatory Syndrome in Children: a step towards a better understanding of this entity
por: Buratti, Cecília Rotava, et al.
Publicado: (2022)